News + Filings Holdings
|
NEA Management Company, LLC
> ADAP
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Adaptimmune Therapeutics PLC | ADAP | 17,079,778 | -1 | 15,798,795,000 | -2,818,163,000 | $925.00 |
| 03/31/2023 | Adaptimmune Therapeutics PLC | ADAP | 17,079,779 | 0 | 18,616,958,000 | -6,319,518,000 | $1,090.00 |
| 12/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 17,079,779 | -2,833 | 24,936,476,000 | 24,918,112,000 | $1,460.00 |
| 09/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 17,082,612 | 0 | 18,364,000 | -10,676,000 | $1.08 |
| 06/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 17,082,612 | 1 | 29,040,000 | -6,150,000 | $1.70 |
| 03/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 35,190,000 | -28,870,000 | $2.06 |
| 12/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 64,060,000 | -24,257,000 | $3.75 |
| 09/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 88,317,000 | 15,545,000 | $5.17 |
| 06/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 72,772,000 | -17,937,000 | $4.26 |
| 03/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 90,709,000 | -1,366,000 | $5.31 |
| 12/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 92,075,000 | -44,244,000 | $5.39 |
| 09/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 136,319,000 | -34,678,000 | $7.98 |
| 06/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 0 | 170,997,000 | 124,532,000 | $10.01 |
| 03/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 17,082,611 | 1,250,000 | 46,465,000 | 27,466,000 | $2.72 |
| 12/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 15,832,611 | 0 | 18,999,000 | -4,908,000 | $1.20 |
| 09/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 15,832,611 | 0 | 23,907,000 | -39,740,000 | $1.51 |
| 06/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 15,832,611 | 0 | 63,647,000 | -4,433,000 | $4.02 |
| 03/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 15,832,611 | 0 | 68,080,000 | -22,958,000 | $4.30 |
| 12/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 15,832,611 | 0 | 91,038,000 | -123,652,000 | $5.75 |
| 09/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 15,832,611 | 2,500,000 | 214,690,000 | 56,432,000 | $13.56 |
| 06/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 13,332,611 | 0 | 158,258,000 | 8,533,000 | $11.87 |
| 03/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 13,332,611 | 1,306,612 | 149,725,000 | 69,391,000 | $11.23 |
| 12/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 12,025,999 | 0 | 80,334,000 | -18,159,000 | $6.68 |
| 09/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 12,025,999 | 0 | 98,493,000 | 44,496,000 | $8.19 |
| 06/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 12,025,999 | 12,025,999 | 53,997,000 | 53,997,000 | $4.49 |
| << Prev Next >> |
|